Wells Fargo’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-3,211
| Closed | -$47.4K | – | 7262 |
|
2024
Q1 | $47.4K | Buy |
3,211
+419
| +15% | +$6.19K | ﹤0.01% | 4895 |
|
2023
Q4 | $37.4K | Buy |
2,792
+619
| +28% | +$8.3K | ﹤0.01% | 4960 |
|
2023
Q3 | $26.8K | Sell |
2,173
-2,273
| -51% | -$28K | ﹤0.01% | 5115 |
|
2023
Q2 | $54.7K | Buy |
4,446
+4,276
| +2,515% | +$52.6K | ﹤0.01% | 5112 |
|
2023
Q1 | $2.09K | Buy |
170
+2
| +1% | +$25 | ﹤0.01% | 5895 |
|
2022
Q4 | $1.93K | Sell |
168
-71
| -30% | -$814 | ﹤0.01% | 5692 |
|
2022
Q3 | $1K | Buy |
239
+117
| +96% | +$490 | ﹤0.01% | 6233 |
|
2022
Q2 | $0 | Buy |
122
+6
| +5% | – | ﹤0.01% | 7699 |
|
2022
Q1 | $0 | Hold |
116
| – | – | ﹤0.01% | 7749 |
|
2021
Q4 | $0 | Hold |
116
| – | – | ﹤0.01% | 7734 |
|
2021
Q3 | $0 | Sell |
116
-20
| -15% | – | ﹤0.01% | 7590 |
|
2021
Q2 | $1K | Sell |
136
-1
| -0.7% | -$7 | ﹤0.01% | 6483 |
|
2021
Q1 | $1K | Hold |
137
| – | – | ﹤0.01% | 6459 |
|
2020
Q4 | $1K | Buy |
137
+5
| +4% | +$36 | ﹤0.01% | 6071 |
|
2020
Q3 | $0 | Buy |
132
+4
| +3% | – | ﹤0.01% | 6920 |
|
2020
Q2 | $0 | Hold |
128
| – | – | ﹤0.01% | 6828 |
|
2020
Q1 | $0 | Buy |
128
+78
| +156% | – | ﹤0.01% | 6833 |
|
2019
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 6528 |
|
2019
Q3 | $0 | Sell |
50
-14
| -22% | – | ﹤0.01% | 6488 |
|
2019
Q2 | $0 | Hold |
64
| – | – | ﹤0.01% | 6447 |
|
2019
Q1 | $0 | Buy |
+64
| New | – | ﹤0.01% | 6369 |
|
2018
Q2 | – | Sell |
-23,942
| Closed | -$151K | – | 6282 |
|
2018
Q1 | $151K | Buy |
23,942
+699
| +3% | +$4.41K | ﹤0.01% | 4911 |
|
2017
Q4 | $187K | Buy |
23,243
+15,991
| +221% | +$129K | ﹤0.01% | 4811 |
|
2017
Q3 | $83K | Sell |
7,252
-3,421
| -32% | -$39.2K | ﹤0.01% | 5065 |
|
2017
Q2 | $104K | Sell |
10,673
-8
| -0.1% | -$78 | ﹤0.01% | 4943 |
|
2017
Q1 | $259K | Sell |
10,681
-128
| -1% | -$3.1K | ﹤0.01% | 4503 |
|
2016
Q4 | $347K | Buy |
10,809
+4,048
| +60% | +$130K | ﹤0.01% | 4309 |
|
2016
Q3 | $338K | Sell |
6,761
-765
| -10% | -$38.2K | ﹤0.01% | 4038 |
|
2016
Q2 | $320K | Sell |
7,526
-1,351
| -15% | -$57.4K | ﹤0.01% | 4029 |
|
2016
Q1 | $585K | Buy |
8,877
+796
| +10% | +$52.5K | ﹤0.01% | 3691 |
|
2015
Q4 | $502K | Buy |
8,081
+2,854
| +55% | +$177K | ﹤0.01% | 3817 |
|
2015
Q3 | $349K | Sell |
5,227
-99
| -2% | -$6.61K | ﹤0.01% | 4041 |
|
2015
Q2 | $518K | Buy |
5,326
+4,309
| +424% | +$419K | ﹤0.01% | 3978 |
|
2015
Q1 | $94K | Sell |
1,017
-52
| -5% | -$4.81K | ﹤0.01% | 4605 |
|
2014
Q4 | $95K | Sell |
1,069
-1,196
| -53% | -$106K | ﹤0.01% | 4600 |
|
2014
Q3 | $157K | Sell |
2,265
-151
| -6% | -$10.5K | ﹤0.01% | 4368 |
|
2014
Q2 | $139K | Sell |
2,416
-1,088
| -31% | -$62.6K | ﹤0.01% | 4446 |
|
2014
Q1 | $139K | Buy |
+3,504
| New | +$139K | ﹤0.01% | 4419 |
|